Mark Lewis: This is the football/oncology crossover I’m here for

Mark Lewis shared a post on X:

“This is the football/oncology crossover I’m here for, ⁦Chiara Cremolini⁩!

I agree KEYNOTE-177 v CheckMate 8HW is fraught with the pitfalls of cross-trial comparison (FWIW, I still favor pembro alone unless I really need a quick response making anti-CTLA4 more worthwhile).”

Source: Mark Lewis/X

Mark Lewis is the Director of Gastrointestinal Oncology at Intermountain Healthcare in Utah, the Co-Chair of adolescent and young adult (AYA) oncology in the SWOG cooperative group, and the Vice President of American Multiple Endocrine Neoplasia Support. Dr. Lewis is also a well-known patient advocate and social media influencer.
.